Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases
Boglárka Soós, Ágnes Szentpétery, Hennie G. Raterman, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 5, pp. 249-257
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
Jiawei Guo, Fuxiao Wang, Yan Hu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100881-100881
Open Access | Times Cited: 122
Osteoporosis pathogenesis and treatment: existing and emerging avenues
Bo Liang, George Burley, Shu Lin, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 113
Insights and implications of sexual dimorphism in osteoporosis
Yuanyuan Zhang, Na Xie, Xiaodong Sun, et al.
Bone Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Development of a Nanohybrid Peptide Hydrogel for Enhanced Intervertebral Disc Repair and Regeneration
Brian Conley, Letao Yang, Basanta Bhujel, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3750-3764
Closed Access | Times Cited: 36
Inflammation and gut dysbiosis as drivers of CKD–MBD
Pieter Evenepoel, Peter Stenvinkel, Catherine M. Shanahan, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 10, pp. 646-657
Closed Access | Times Cited: 26
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases
Frank Buttgereit, Andriko Palmowski, Milena Bond, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 7, pp. 417-431
Closed Access | Times Cited: 13
Unraveling the molecular and immunological landscape: Exploring signaling pathways in osteoporosis
Morteza Nakhaei Amroodi, Mazaher Maghsoudloo, Shayan Amiri, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116954-116954
Open Access | Times Cited: 7
Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis
Peter Pietschmann, Maria Butylina, Katharina Kerschan‐Schindl, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8740-8740
Open Access | Times Cited: 26
Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics
Liuting Zeng, Ganpeng Yu, Kailin Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Tricarboxylic Acid Cycle Regulation of Metabolic Program, Redox System, and Epigenetic Remodeling for Bone Health and Disease
Wei Lian, Re‐Wen Wu, Yu-Han Lin, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 470-470
Open Access | Times Cited: 4
Targeting TRPC channels for control of arthritis-induced bone erosion
Suravi Ray, Jamie L. McCall, Jinbin Tian, et al.
Science Advances (2025) Vol. 11, Iss. 3
Closed Access
The serum level of sclerostin decreases in radiographic axial spondyloarthritis patients with fatty lesions
Xuegang Li, Haijian Jiang, Xu Wang, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access
Oleandrin inhibits osteoclast differentiation by targeting the LRP4/MAPK/NF-κB signalling pathway to treat osteoporosis
Chongxin Xiang, Jiankang Cao, Rui Hu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114073-114073
Closed Access
YOLOv11-based multi-task learning for enhanced bone fracture detection and classification in X-ray images
W. Wei, Y. Huang, J. P. Zheng, et al.
Journal of Radiation Research and Applied Sciences (2025) Vol. 18, Iss. 1, pp. 101309-101309
Closed Access
Multifunctional hydrogel microspheres regulate the balance of osteoblastic-osteoclastogenesis to treat osteoporotic bone defects by the NFATc1/RANKL/MAPK signaling
Dongping Wang, Jiamin Yang, Chang Liu, et al.
Composites Part B Engineering (2025), pp. 112195-112195
Open Access
Systemische versus lokale Demineralisation bei der rheumatoiden Arthritis
Tobias Hoffmann, Christina Pflug, Wiebke Schulze, et al.
Zeitschrift für Rheumatologie (2025)
Closed Access
Enhanced Bone Targeting of Poly(l-glutamic acid)s through Cationic or Aromatic Substitution
Xiaoxiong Jin, Wanying Wang, Hui Liu, et al.
Biomacromolecules (2025)
Closed Access
Multi‐Core Functional Microspheres for Osteoporotic Bone Defects Therapy: From Local Treatment to Systematic Relief
Jie Cao, Zhihui Han, Shumin Sun, et al.
Advanced Functional Materials (2025)
Closed Access
JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
Mariely Araújo de Godoi, Ângelo Constantino Camilli, Karen G. A. Gonzales, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10290-10290
Open Access | Times Cited: 7
Positive Effects of Biologics on Osteoporosis in Rheumatoid Arthritis
Yunkyung Kim, Geun-Tae Kim
Journal of Rheumatic Diseases (2022) Vol. 30, Iss. 1, pp. 3-17
Open Access | Times Cited: 11
Harnessing osteoimmunity to treat peri-implant inflammatory osteolysis
Zijun Chen, Di Wang, Rui Yang, et al.
Materials Advances (2024) Vol. 5, Iss. 8, pp. 3113-3134
Open Access | Times Cited: 2
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis
Francesco Caso, Mauro Fatica, Mario Ferraioli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 719-731
Closed Access | Times Cited: 2
The Effect of Anti-rheumatic Drugs on the Skeleton
Barbara Hauser, Hennie G. Raterman, Stuart H. Ralston, et al.
Calcified Tissue International (2022) Vol. 111, Iss. 5, pp. 445-456
Open Access | Times Cited: 9
Serum DKK-1 level in ankylosing spondylitis: insights from meta-analysis and Mendelian randomization
Xi Fang, Cong Chen, Zhixin Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis
Haruka Tsuchiya, Mineto Ota, Haruka Takahashi, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top